Modulation of NRF2/ARE pathway- and cell death-related genes during drug-induced liver injury

B Y Ghanim1, M I Ahmad2, Q M Abdallah1,3

  • 1University of Petra Pharmaceutical Center (UPPC), University of Petra, Amman, Jordan.

Insights

The NRF2 pathway

Area of Science:

  • Hepatology
  • Molecular Toxicology
  • Biomarker Discovery

Background:

  • Drug-induced liver injury (DILI) is a significant clinical issue linked to oxidative stress and cell death.
  • The Nuclear factor erythroid 2-related factor 2 (NRF2) pathway is crucial in liver pathologies, but its efficacy in severe DILI is uncertain.
  • Understanding NRF2's role in DILI progression and its potential as a biomarker is critical.

Purpose of the Study:

  • To assess NRF2 as a biomarker for DILI severity.
  • To investigate factors influencing Nrf2 expression during DILI.
  • To explore the interplay between NRF2 signaling, oxidative stress, and cell death in acetaminophen-induced liver injury.

Main Methods:

  • Established an in vivo DILI model in C57BL/6 mice using varying acetaminophen (APAP) doses.
  • Confirmed APAP toxicity through dose-dependent liver pathology and in vitro GSH/SOD depletion in primary hepatocytes.
  • Analyzed NRF2 translocation, cytosolic content, and gene expression (ARE genes, apoptotic genes, necrosis-related genes) via molecular assays.

Main Results:

  • Mild APAP exposure (70 mg/kg) increased NRF2 transcription and translocation but downregulated key antioxidant response element (ARE) genes (Hmox1, Nqo1, Glcm) and apoptotic genes (Bcl2).
  • Necrosis inducer Parp2 was upregulated, while Hmgb1 was downregulated, indicating regulation of cell survival genes at subtoxic doses.
  • Higher APAP doses led to severe hemorrhagic necrosis and impaired transcription of NRF2 and other critical genes.

Conclusions:

  • NRF2/ARE pathway and cell death modulation are compromised with increasing chemical stress in DILI.
  • NRF2 pathway function is directly associated with the severity of drug-induced liver injury.
  • NRF2's regulatory capacity diminishes as DILI progresses, highlighting its complex role in liver protection and injury.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
39
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.4K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
38
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.9K